NEUROLEPTIC MALIGNANT SYNDROME
John D. Scarlett, Robert A. Zimmerman, Samuel F. Berkovic
Abstract
John D. Scarlett, Robert A. Zimmerman, Samuel F. Berkovic
Abstract
Abstract: Two cases of neuroleptic malignant syndrome (NMS) are presented. This rare pattern of neuroleptic drug toxicity is characterised by fever, muscular rigidity, akinesia and elevated plasma creatine kinase. The condition may be fatal and early recognition is essential. Evidence is presented that NMS is unrelated to malignant hyperpyrexia.
OpenAlex reports 35 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract: Two cases of neuroleptic malignant syndrome (NMS) are presented. This rare pattern of neuroleptic drug toxicity is characterised by fever, muscular rigidity, akinesia and elevated plasma creatine kinase. The condition may be fatal and early recognition is essential. Evidence is presented that NMS is unrelated to malignant hyperpyrexia.
Key concepts: Neuroleptic malignant syndrome, Medicine, Creatine kinase, Muscle Rigidity, Toxicity, Rhabdomyolysis, Drug, Anesthesia